← All trials
NCT01040390
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2010
- Primary completion
- Dec 1, 2011
- Completion date
- Dec 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 34
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Department of Indian Systems of Medicine and HomeopathyLead sponsor
- Department of Indian Systems of Medicine and HomeopathyReponsible party - principal investigator
- Department of Indian Systems of Medicine and HomeopathyOverall official - principal investigator
- Department of Indian Systems of Medicine and HomeopathyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.